BeiGene
BGNE
#880
Rank
HK$178.75 B
Marketcap
HK$1,597
Share price
-0.65%
Change (1 day)
2.73%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: HK$3,134 HKD on 2021-09-17

Lowest end of day price: HK$186.42 HKD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
HK$7.74-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.82 4.83%๐Ÿ‡บ๐Ÿ‡ธ USA